Healthcare & Life Sciences
DreaMed Diabetes
Israeldreamed-diabetes.com/
DreaMed Diabetes is a Healthcare & Life Sciences startup based in Israel, most recent round Series C+, 3 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2014
Founded
3
Investors
About DreaMed Diabetes
DreaMed Diabetes is a company founded in 2014 headquartered in Israel. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
DreaMed Diabetes develops AI-powered decision support systems for insulin dose optimization. Their cloud-based platform helps healthcare providers manage diabetes patients more effectively.
Explore DreaMed Diabetes's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.